Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-03-21
1987-05-12
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514425, 514508, 514912, A61K 3140, A61K 31215
Patent
active
046650890
ABSTRACT:
Cataract in mammalian lenses can be prevented or reversed by applying a solution of an imidoester, a N-hydroxysuccinimide-ester or hydrogen peroxide to the lens under conditions that permit the solution to interact with the lens constituents.
REFERENCES:
patent: 4150120 (1979-04-01), Ono
patent: 4351826 (1982-09-01), Clark
patent: 4451477 (1984-05-01), Silvestrini et al.
patent: 4474817 (1984-10-01), Clark
Chem. Abst. 81:1550p (1974)-Raubach et al.
Chem. Abst. 97:141268h (1982)-Nemes et al.
Benedek George B.
Coppin Christophe M.
Siezen Roelant J.
Cook Paul J.
Massachusetts Institute of Technology
Robinson Douglas W.
LandOfFree
Process for preventing or reversing cataract formation using pro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preventing or reversing cataract formation using pro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preventing or reversing cataract formation using pro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802683